U-Neuron Biomedical (6973.TWO) has a profit margin of -68.01%, below the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
As of the most recent data (June 2026), 6973.TWO shows a profit margin of -68.01%. That is below the Healthcare sector average of 17.63%. Scroll down for historical charts and peer comparison views.
The Healthcare sector average profit margin is about 17.63%. U-Neuron Biomedical is at -68.01%, which is lower that average. That is roughly 485.8% below the sector mean. Use the comparison chart on this page to see how 6973.TWO stacks up against individual peers as well.
Check the historical chart to see whether 6973.TWO's profit margin is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare U-Neuron Biomedical with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has U-Neuron Biomedical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -68.01%) with ownership activity and broader fundamentals.
The Healthcare average profit margin is about 17.63%, while 6973.TWO is at -68.01%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.